http://www.onclive.com/onclive-tv/dr-finn-on-regorafenib-for-the-treatment-for-patients-with-hcc
Dr. Finn on Regorafenib for the Treatment of Patients With HCC

Richard S. Finn, MD


Richard Finn, assistant professor of Medicine at the Geffen School of Medicine, Department of Medicine, Division of Hematology/Oncology at UCLA Jonsson Comprehensive Cancer Center, discusses regorafenib (Stivarga) for the treatment of patients with hepatocelluar carcinoma (HCC).
Printer Printing...